CLASS II Drug recall · Reported 17 Jun 2020 · FDA Enforcement Report

Lisinopril Tablets, USP, 5 mg recalled by Lupin Pharmaceuticals

Lupin Pharmaceuticals is recalling Lisinopril Tablets, USP, 5 mg, distributed nationwide in the US. The recall was initiated on 28 May 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # Q900683, Exp. 10/31/2022
NDC68180-512, 68180-513, 68180-517, 68180-980, 68180-981, 68180-982
UPC0368180513018, 0368180512028, 0368180513032
Quantity recalled4,224 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1290-2020
FDA event ID
85770
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class II
Status
Terminated
Recall initiated
28 May 2020
FDA classified
8 Jun 2020
Reported
17 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

28 May 2020Recall initiated by company
8 Jun 2020Classified by FDA+11 days
17 Jun 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Product as listed by the FDA

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Where it was distributed

Nationwide within the US.

Nationwide

Questions about this recall

Is Lisinopril Tablets, USP, 5 mg recalled?

Yes. Lupin Pharmaceuticals recalled Lisinopril Tablets, USP, 5 mg on 28 May 2020. The recall is Class II and its status is Terminated. Recall number D-1290-2020.

Why was it recalled?

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Which lots are affected?

Lot # Q900683, Exp. 10/31/2022

Where was it sold?

Nationwide within the US.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsSterilityNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide

Other Lisinopril recalls

All 34